Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint

D. R. VanDevanter, A. Yegin, W. J. Morgan, S. J. Millar, D. J. Pasta, M. W. Konstan

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint'. Together they form a unique fingerprint.

Medicine & Life Sciences